[Long-time treatment with full-dosage ranitidine in a case of myelodyserythropoiesis (blastic leukosis) treated with prednisone and antiblastic agents].
De Gaetano
G
G
Sonnino
A
A
D000368:Aged; D000754:Anemia, Refractory, with Excess of Blasts / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D011899:Ranitidine / Q000008:administration & dosage*
D011899:Ranitidine; D015122:Mercaptopurine; D011241:Prednisone; D006918:Hydroxyurea
Trattamento long-time con ranitidina a dosaggio pieno in un caso di mielodiseritropoiesi (leucosi a blasti) in cura con prednisone e antiblastici.